Clarke Futch (Healthcare Royalty)

Roy­al­ty Phar­ma com­peti­tor stirs the pot with plans for $750M IPO

Os­ten­si­bly aim­ing to pig­gy­back off the suc­cess of Roy­al­ty Phar­ma and CEO Pablo Legor­re­ta’s IPO in June 2020, an­oth­er roy­al­ty-gob­bling com­pa­ny is near­ly set to do the Nas­daq shuf­fle.

Health­care Roy­al­ty, a Stam­ford, CT-based com­pa­ny found­ed by life sci­ences in­vest­ing vet Clarke Futch, has set the terms for a $750 mil­lion IPO ex­pect­ed to price next week, ac­cord­ing to Re­nais­sance Cap­i­tal. The like­ly fig­ure is still dwarfed by Legor­re­ta’s $2.2 bil­lion raise a lit­tle over a year ago, but should Health­care Roy­al­ty match its terms, it would be larg­er than any biotech IPO so far in 2021, per the End­points News tal­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.